Nucleophosmin is overexpressed in thyroid tumors.

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Nucleophosmin (NPM) is a protein involved in various cellular functions, with roles as both an oncogene and tumor suppressor.
• Limited data exists on NPM expression in thyroid cells, necessitating further investigation into its role in thyroid tumorigenesis.

Purpose of the Study:

• To investigate NPM mRNA and protein expression in human thyroid tumor tissues and cell lines.
• To determine if NPM overexpression is an early event in thyroid cancer development.
• To elucidate the regulatory mechanisms underlying NPM expression in thyroid cells, particularly the role of post-transcriptional regulation and signaling pathways.

Main Methods:

• Immunohistochemistry was used to assess NPM protein levels in thyroid tumor tissues and cell lines.
• Quantitative RT-PCR was employed to measure NPM mRNA levels in tumor tissues and FRTL5 cell lines.
• Correlation analyses were performed to link NPM protein and mRNA levels with proliferation states.
• Experiments with thyroid tumor cell lines were conducted to explore the interaction of NPM with p-Akt and PTEN.

Main Results:

• NPM overexpression was detected in various thyroid tumors, including papillary, follicular, and undifferentiated cancers, as well as benign follicular adenomas.
• A dissociation between NPM protein and mRNA levels was observed in tumor tissues and normal FRTL5 thyroid cells.
• NPM protein levels, but not mRNA, positively correlated with the proliferation state in FRTL5 cells.
• NPM binding to p-Akt, which was elevated in tumor cells alongside reduced PTEN, was identified as a potential post-mRNA regulatory mechanism.

Conclusions:

• Nucleophosmin is overexpressed in thyroid tumors, representing an early event in thyroid tumorigenesis.
• The observed NPM overexpression is primarily due to post-transcriptional dysregulation, not transcriptional changes.
• Increased p-Akt levels in transformed thyrocytes appear to contribute to the post-transcriptional regulation of NPM protein levels.